| Schedule of financial statements |
|
| Year Ended December 31, 2019
|
|
|
|
| As Previously
Reported
|
|
| Adjustment
|
|
| As Revised
|
|
| Consolidated Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
| General and Administrative – Patent Amortization
|
| $ | 5,697,469 |
|
|
| 89,623 |
|
| $ | 5,787,092 |
|
| Total Operating Expenses
|
|
| 8,373,625 |
|
|
| 89,623 |
|
|
| 8,463,248 |
|
| Loss from operations before income taxes
|
|
| (10,587,124 | ) |
|
| (89,623 | ) |
|
| (10,676,747 | ) |
| Net loss
|
|
| (10,587,124 | ) |
|
| (89,623 | ) |
|
| (10,676,747 | ) |
| Net loss attributable to common shareholders
|
|
| (11,286,939 | ) |
|
| (89,623 | ) |
|
| (11,376,562 | ) |
| Net loss per share, basic and diluted
|
|
| (3.63 | ) |
|
| (0.03 | ) |
|
| (3.66 | ) |
| Number of weighted shares
|
|
| 3,107,580 |
|
|
| — |
|
|
| 3,107,580 |
|
|
|
| As of December 31, 2019
|
|
|
|
| As Previously
Reported
|
|
| Adjustment
|
|
| As Revised
|
|
| Consolidated Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
| Patents and trademarks, net
|
| $ | 1,798,484 |
|
|
| (653,596 | ) |
| $ | 1,144,888 |
|
| Total Assets
|
|
| 20,204,844 |
|
|
| (653,596 | ) |
|
| 19,551,248 |
|
| Accumulated deficit
|
|
| (114,084,746 | ) |
|
| (653,596 | ) |
|
| (114,738,342 | ) |
| Total stockholders’ equity
|
|
| 19,854,545 |
|
|
| (653,596 | ) |
|
| 19,200,949 |
|
|
|
| Year Ended December 31, 2019
|
|
|
|
| As Previously
Reported
|
|
| Adjustment
|
|
| As Revised
|
|
| Consolidated Cash Flows Operating Activities Data:
|
|
|
|
|
|
|
|
|
|
| Net loss
|
| $ | (10,587,124 | ) |
|
| (89,623 | ) |
| $ | (10,676,747 | ) |
| Amortization of Patents
|
|
| — |
|
|
| 89,623 |
|
|
| 89,623 |
|
|